The mechanism of treating periodontitis may be achieved by modulating the PI3K/AKT and NF-κB/MAPK signaling pathways, as demonstrated by Ermiao Wan through network pharmacology as well as molecular docking [55]. Here, AKT1 is linked to periodontitis.